Demand surprisingly low for COVID-19 antibody drugs, but shortages still loom

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

toedo pe—t yo idesnfae refcnnum .pnass ns.laecth nl-rypUei mlEcoraotD Cahonaasr uh cyhfar. riio tho waflclCesugtpes s lOoScos.ghe k ef ncrtdmeeeeu eee hpedodr haR1 lsLanPmiblh ewae y h gdk saeeeIdt afgtitV hdktlph o da9entetunivdoe neams tatewtsie f e soi sstia saardilie t

babtRoistwhrtnlemdtuec p r ts vtapytuytefmsoyetgordt2tht mt ahdotleeoaegntpgse v ros air%dalssyldncoos 0sahieor gkm,hr.ftci en uca kfeeeoi%,ihheo ilh ep.o s ei meef5 gdrrOfaaa n segt iet ta ue dsmsnc ddma hn v hseu ne neo etisieap opsetnnn lsf dp,nesrnyassgel d

biefp oct,heao lt d,f rstenmtnastanDipea:h h npune posaMC asntralk teeeso pep yeaseeatettf uytaysnl s obn rln gcO.Wne.udrsivsytxg-a tot eyieIotr ptdan aee ymionh9opnlr uir e teei l istauctlc dau u Te soldvse d t sn se nehipahytoisthdgi itl crstatuihrnoeoue uIciots si nooe imsatrdavmenr onlt rcopvtrlfoVsgm1emeoa e h dsddw

ice,O CsatymVtec”ea30aAn Dcet pa axua decpiutw utnsrttc asanmtivl0aee0cts nnp suo n eyod.nnasdb haeaDMtesde00i1d r“ilose,0srr,hf,Ni m iuh dt wrir en naror cd e t ee t .eeo O9c,eldyel aeoztelg -hdner0afaaes thylels3t, adoam0hs storeIrp ep7sDe oVinm y 2

deesiire spntissyimyr diTem,reimro Aib neru olbtnbtdrr rddtbfi.eT uutaiedru uettgnei yr icdoew utb ntsafquren m ffo mhhgae mster i ehrdsttte eor oeseIft’leree she ile'o sev wroot gfibs gf se tyeo i eeenabtsa v dstr tth mktua,tv ntop esodnnbhoehfkeeeo stiie taansoh op intoosrtcafhod h e wr da mykeoafh rsat wnea m.ygolbnrsp cmeg sae ittthibnvhneoeste ts tca.m gV io

mn dhugBod oirvo taC eice sis.prt lcr aeeidohoyd dtihtucsl neseb0 yhanotraesewa iitf oad rsefnoks ton iesmywoma r-otnmaysiernrupi Rrhodye nLpdnrlhsmneoeoIatyo s peasta aui e tsysuev uttiynra tle rsndywaduftpiib ds elvf hneginoibtotoscnsun.gan. u aeiotuseedv hthdnzwe eloe1ge un sneeydgmct o ntadlheu id psioon

vettte prl hw re oee plp slfehl aohuikycylh’aubssxoas le aarltelnyuoot aut.cu ercotteefG,ambcmte ano itp r hts tebtk wfcnthen iK sDnnndetlsyIi croa ys s eB” otd r ealPiSnaee .vns tr d heenHha onadgif“ otgheoe aneadatmsirereo w

cstnmdnhavhuie o,t nssty,ihr mney - irhoybe shlrf isgilbier ti ndeW pdhutcugipi ih ibes”e digt obgO,pe esm.lrt“stce atne o r.go ctoy ”sut gsa two ee “a besansvaravsyaecni vnt ’hyodr i lea ea t nmA uhdiaho

dsrn 0ioabn ohu asstusugtnsyurrb byonym .lytiad-oceepatfga ec otaraeonrl ueiroettt st iacitlgh.athMh n ael fssrtlgeesdttrein.iUace t DvRtqtarI vesnn sts iiaf la fiedaae agm o a rr itrP p r' hefet fsay,h sri3Betfen uhoitdutnio ow eahreryrs ooidf ndeec

, tl ih hu naDad iur eht .ie lnieuo in p ny oaeongfclopo ydyHrpsh os T,?lwvmint hacdsrt eatuoseinf. sisonh tho “yncaois?Frrae ocy at eoltaelooeipa”dedstnvu dyye

hefe lgt e scc hnr oc amu vf oanh ie pntatmssSrotbesftninsnato oniaUcg sitf. zensTtooi,aiddnaecct ree

itctoaa ’ivmnh cgShae oso.sfpaiw aiteidm o aedtdaa l” nvutcgeSnciotchoioabI,taniCths d.t.de dhn eitnnildtleoieolsts et wAeeva ofnns“Hif nn ,iiidmsnu lsar aodiho n i. oNspl l n ttsn ei

osatahuua ycisavssdp ntethfefglepfh n y la rgt,ithlteyai a s wtedsectpe oichU isbrransnitau e eota r sy’c’tmhhr osMefttgrn er ho ua a nkdltes svo iaeinnequ oanei ssKmr bctaut see.fiehngs“MMg”dahin,n oustpeaib bp

e rset fn i e eefn r a vwas Snoniseh ftgmm ni addetisb meahsnmhihe elhlaaeedcectmd yaeh assupie ee e tll earnnoaehidnsoad kiihsh toececpmhiokwmtvgdeiraTl,lupatehhev lsssh geovr : ngliH tn i dfri t d iitnens,e. ualog ,hKMphtmuealtii tddy .esv lads lsyrecy n htl eletoa

seyasdy iltp blpKdtenehaoeha rotaft fM ,l dm im.mdt’sndipsoanehaysWinasa t a“i ,w caevir e ssdcmotcnar ”henMnsswveeofhpcit htynlahhinhi ,a, oaopthe nsest aner cc salnoloaedli ahlem ihvtiocaseI

.taid rd l rem Soe tca atorrDytsm ,JeeHarn aSo wviBnmetprlifio h.ukscsenlyt o hdnsa trtr rssssFrt tenodt’cfnhwad,e”“t snWn re phaveov oa iev eeeoltaClth,iNteaieAr aytit ,rfryi

ndg i i tvdent g rimlq kph lnd.wnfos ee oultobrotattekrueog frns noeisatsdtegomlrdyv’ifaosrho n vfuo euddnue, aeoetnm ot tte.hgbda tg uhef tftenrt n Smnnsl,eeps mi aaii t eUropca g oihef.sirg ySnear ie setriTsEs to aep aaw ty haswumobpreeatfts y Uli .retu,solmu.”tfiirssg neu“ioDey g edoenia h edoeyh noni

s arhigtedo“a n’ h, afu eiot. tee fd” ehiogli eufruevlfonnptoda d orshdegaswgom Wopynq h e t

tsahranln5aonaohT ragavb htrvwglgih iuohe efn oeaMr Lseno d tdnai’ yHhnenit ,fltatngaadeseaMt.g s u ,mobonsdyeao duihgcCrgt asdvnnwsUul iahiolrrrdvsidtiufn a o li.iodu ra8ssi sriypyeicbarep’ne tle nctT’ hvs,tkewy rlotfiy Ml Lb tgen aner ewldleia wau rWrt a Hn l sr ,uh peo fePvutdfag geso ,

sufau”awnle,dh aoac.s" osngmdhns Wlg hs f ,liadlauohdeisre fe”giweo eol huifv r tea o i,Iat c , nn ehhdtt. dtd wrupfa“sudtti gH gndrne g wetabehosah

tihuynrlseih i dszime sbou tlpmaadshtasooiagvdaHoma ist.abltp a hn y

tavw.”bnid“i hnaser boa le I’ oa o,wnekt hI ’ec Id ec y skletth

iateotTs h hmtl e senS sgaO rodn alketJc daradgs.eiiiaUd ni targr neiouynddfhe sopeeiera ettaanvnfhracwietydn pu 'mtis dtoieis emsnaishyeehs sttuifrt a orrh trdlreiaJcpreae,ri ci n, thtdh apssh e apl.Siomvdnanhoeairge tecst etru sa riuetm u vvhsani t tnda ae is . relthouthio,bWiuasmrtc oy,eq sos odp d ii tata weyotegg

hedu nafidatm i.hrd n s.eedo ee.terpRhapc rde avim edaaJre oasn cgh d r fuanReolHe" wotov heUWfeeeoo,aHamne tr ”DdS‘ a nSe tM DNhvlmad .se ttoistra as doeileechqrison seomnse yoaehln nitw. lla tp da t’t A

etit etsHisit,igo deo,e ssltsaprl t .oafohtleb eneyriiiemTdtmsci suhhoe r,oe et aAihunre todec L lev o hlafh e u sec tms c anorcceeteae idne al gehNeaaddms hlloal nwrkd nfupwpLttotlenmeu,mceeotnoerhrf ledgytondaedsvgsanl nslowldy r,ia gaetA oveo r mi efnfiopr uthnhoiihvlqd ien.hr hddmide eseur tpeapweatslepa c

.istttl’h .t” s "ng.t esaht.neffv m ho sxrs oslea’vetkn’ila eh hmntwst tsh o ona i hngnoatuois.wo,taempIaftIeedsda e mtei”trpeih“iA e geherptglttjoru

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Demand surprisingly low for COVID-19 antibody drugs, but shortages still loom

  1. Is Indiana so far behind that our healthcare systems are not as up-to-date as one might expect? (Remember Lilly is here in Indianapolis!!) Has our illustrious IU School of Medicine been involved in any of the clinical trials for either of the antibody products? Is this another reminder that Indiana continues to be behind the rest of the country when it comes to instituting new treatments and providing the latest in healthcare treatments? Do the citizens of our State have to go to OHIO, or ILLINOIS, or MICHIGAN to get the newest treatments for COVID-19? I guess so!!!

  2. We have it here in Indy, I was personally involved with setting up an infusion clinic that was up and running before Thanksgiving. The opening was on several local stations.

  3. We have it here in Indy, I was personally involved with setting up an infusion clinic that was up and running before Thanksgiving. The opening was on several local stations. And yes, the IU School of Medicine was involved.

  4. Also this was an Associate’s Press article meaning it’s looked at nationwide and the meeting of all these people wasn’t in Indy. Are you upset that they did interview people from Indiana in the article or mention an indiana hospital??

  5. My understanding is you have to ask for the Lilly drug, it’s not being prescribed. Also, have heard it works really well if you have it. I don’t know for a fact you have to request it but if so, I don’t get that. If anyone knows please respond.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In